161 related articles for article (PubMed ID: 37699356)
21. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
22. The molecular biology of sporadic acromegaly.
Marrero-Rodríguez D; Moscona-Nissan A; Sidauy-Adissi J; Haidenberg-David F; Jonguitud-Zumaya E; de Jesus Chávez-Vera L; Martinez-Mendoza F; Taniguchi-Ponciano K; Mercado M
Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101895. PubMed ID: 38641464
[TBL] [Abstract][Full Text] [Related]
23. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.
Tebani A; Jotanovic J; Hekmati N; Sivertsson Å; Gudjonsson O; Edén Engström B; Wikström J; Uhlèn M; Casar-Borota O; Pontén F
Acta Neuropathol Commun; 2021 Nov; 9(1):181. PubMed ID: 34758873
[TBL] [Abstract][Full Text] [Related]
24. KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas.
Chasseloup F; Regazzo D; Tosca L; Proust A; Kuhn E; Hage M; Jublanc C; Mokhtari K; Dalle Nogare M; Avallone S; Ceccato F; Tachdjian G; Salenave S; Young J; Gaillard S; Parker F; Boch AL; Chanson P; Bouligand J; Occhi G; Kamenický P
Eur J Endocrinol; 2024 Feb; 190(2):173-181. PubMed ID: 38330165
[TBL] [Abstract][Full Text] [Related]
25. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas.
Tang Y; Xie T; Wu S; Yang Q; Liu T; Li C; Liu S; Shao Z; Zhang X
Endocrine; 2021 Nov; 74(2):375-386. PubMed ID: 34043183
[TBL] [Abstract][Full Text] [Related]
27. Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.
Herrgott GA; Asmaro KP; Wells M; Sabedot TS; Malta TM; Mosella MS; Nelson K; Scarpace L; Barnholtz-Sloan JS; Sloan AE; Selman WR; deCarvalho AC; Poisson LM; Mukherjee A; Robin AM; Lee IY; Snyder J; Walbert T; Rosenblum M; Mikkelsen T; Bhan A; Craig J; Kalkanis S; Rock J; Noushmehr H; Castro AV
Neuro Oncol; 2022 Jul; 24(7):1126-1139. PubMed ID: 35212383
[TBL] [Abstract][Full Text] [Related]
28. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
Asa SL; Mete O; Riddle ND; Perry A
Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
[TBL] [Abstract][Full Text] [Related]
29. Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors.
Cui Y; Li C; Jiang Z; Zhang S; Li Q; Liu X; Zhou Y; Li R; Wei L; Li L; Zhang Q; Wen L; Tang F; Zhou D
Neuro Oncol; 2021 Nov; 23(11):1859-1871. PubMed ID: 33908609
[TBL] [Abstract][Full Text] [Related]
30. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro.
Kontogeorgos G; Asa SL; Kovacs K; Smyth HS; Singer W
Acta Endocrinol (Copenh); 1993 Dec; 129(6):565-72. PubMed ID: 7509101
[TBL] [Abstract][Full Text] [Related]
31. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
Rak B; Maksymowicz M; Pękul M; Zieliński G
Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
[TBL] [Abstract][Full Text] [Related]
32. Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors.
Wang L; Wei C; Wang Y; Huang N; Zhang T; Dai Y; Xue L; Lin S; Wu ZB
Front Endocrinol (Lausanne); 2023; 14():1149997. PubMed ID: 37534217
[TBL] [Abstract][Full Text] [Related]
33. The Integrated Stress Response Is Tumorigenic and Constitutes a Therapeutic Liability in Somatotroph Adenomas.
Li Z; Chen Y; Yao X; Liu Q; Zhu H; Zhang Y; Feng J; Gao H
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361871
[TBL] [Abstract][Full Text] [Related]
34. The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.
Salomon MP; Wang X; Marzese DM; Hsu SC; Nelson N; Zhang X; Matsuba C; Takasumi Y; Ballesteros-Merino C; Fox BA; Barkhoudarian G; Kelly DF; Hoon DSB
Clin Cancer Res; 2018 Sep; 24(17):4126-4136. PubMed ID: 30084836
[No Abstract] [Full Text] [Related]
35. Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma.
Ashton C; Rhie SK; Carmichael JD; Zada G
J Neurosurg; 2020 Feb; 134(3):787-793. PubMed ID: 32109873
[TBL] [Abstract][Full Text] [Related]
36. [Neuroimaging of Pituitary Neuroendocrine Tumors].
Kurosaki M
No Shinkei Geka; 2023 Jul; 51(4):634-641. PubMed ID: 37491060
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST
Pedraza-Arevalo S; Ibáñez-Costa A; Blázquez-Encinas R; Branco MR; Vázquez-Borrego MC; Herrera-Martínez AD; Venegas-Moreno E; Serrano-Blanch R; Arjona-Sánchez Á; Gálvez-Moreno MA; Korbonits M; Soto-Moreno A; Gahete MD; Charalambous M; Luque RM; Castaño JP
Mol Oncol; 2022 Feb; 16(3):764-779. PubMed ID: 34601790
[TBL] [Abstract][Full Text] [Related]
38. Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment.
Trouillas J; Vasiljevic A; Lapoirie M; Chinezu L; Jouanneau E; Raverot G
Minerva Endocrinol; 2019 Jun; 44(2):129-136. PubMed ID: 30531694
[TBL] [Abstract][Full Text] [Related]
39. A review of multiomics platforms in pituitary adenoma pathogenesis.
Mouchtouris N; Smit RD; Piper K; Prashant G; Evans JJ; Karsy M
Front Biosci (Landmark Ed); 2022 Mar; 27(3):77. PubMed ID: 35345309
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.
Mosella MS; Sabedot TS; Silva TC; Malta TM; Dezem FS; Asmaro KP; Wells M; Mukherjee A; Poisson LM; Snyder J; deCarvalho AC; Walbert T; Aho T; Kalkanis S; Elias PC; Antonini SR; Rock J; Noushmehr H; Castro M; Castro AV
Neuro Oncol; 2021 Aug; 23(8):1292-1303. PubMed ID: 33631002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
